Skip to main content

Breast Cancer Clinical Trials

Review the breast cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 426-450 of 919

Safety and Feasibility of Robotic Single-Port Nipple Sparing Mastectomy.
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients with Breast or Lung Cancer
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Accelerator Based Stereotactic Body Radiation Therapy after Surgery in Treating Patients with Early Stage Breast Cancer
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
A Precision Oncology Navigation and Expert Review Intervention for Improving Referral to Genome Informed Therapy among Patients with Stage IV Lung, Colorectal, Breast or Bladder Cancers, PROGRESS Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Status: Active
Location: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Status: Active
Location: 2 locations
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Status: Active
Location: UPMC Hillman Cancer Center Erie, Erie, Pennsylvania
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Status: Active
Location: See ClinicalTrials.gov
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
Status: Active
Location: See ClinicalTrials.gov
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
Status: Active
Location: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Status: Active
Location: See ClinicalTrials.gov
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Status: Active
Location: See ClinicalTrials.gov
Evaluation of AP-002 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Status: Active
Location: See ClinicalTrials.gov
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Status: Active
Location: See ClinicalTrials.gov
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov